DRDO issues directions on usage of anti-Covid drug
New Delhi: In a bid to tackle mis-information on social media regarding the Covid therapy drug ‘2DG’, the Defence Research and Development Organisation (DRDO) on Tuesday tweeted the usage of the drug and again advised people on who all can be its users. “Doctors can prescribe the drug as early as possible for moderate to severe Covid patients for maximum duration of 10 days. The impact of the drug on patients with uncontrolled diabetes, severe cardiac problem, severe hepatic and renal impairment has not been studied yet, hence caution should be exercised,” the DRDO said in tweet. TNS